Stock Evaluator: Microbot Medical Inc. (MBOT)

Microbot Medical Inc. MBOT

$1.46 -0.01 -0.68%
September 2, 2026 4:00:00 PM EST November 10, 2021 Volume: 536,963
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body’s vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Commentary & Analysis


Financial Summary

Share Statistics MBOT Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $98.7 $405.9 21%
Shares Out (Mil) 67.2 41.6 54%
Institutional Ownership na 83.1% na
Float (Mil) 67.2 35.6 54%
Beta 1.05 0.88 63%
Avg Daily Volume (000s) 594 337 62%
Price Change
(52-week)
(61.4%) 65.0% 11%
Growth MBOT Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 11.8% na
Net Income (5yr) (7.3%) (5.9%) 31%
EPS (5yr) 25.9% 10.2% 76
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) 15.0% (15.6%) 73%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 3 3 3
Current EPS ($0.083) ($0.313) ($0.343)
Month Ago EPS ($0.073) ($0.280) ($0.297)
# Rev Up 1 1 1
# Rev Down 0 0 0
Three Months Ago EPS ($0.080) ($0.310) ($0.280)
Year/Year Chg (1.2%) 9.1% (2.4%)
Financials MBOT Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $0 $119 1%
Net Income (TTM) (Mil) ($16) ($9) 25%
EPS (TTM) ($0.262) ($0.400) 32%
Operating Cash Flow (TTM) (Mil) ($18) ($3) 16%
Net Cash Flow (TTM) (Mil) na $1 na
Long-Term Debt (Q1) (Mil) $1 $22 15%
Enterprise Value (Q1) (Mil) $38 $371 14%
Valuation MBOT Industry
Median
Percentile
(All Stocks)
P/B 1.43 3.04 37%
P/E na 27.4 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.6 na
Ratios MBOT Industry
Median
Percentile
(All Stocks)
Gross Margin (185.3%) 58.5% 1%
Net Margin na (6.9%) na
ROA (30.7%) (13.1%) 17%
ROE (32.9%) (13.1%) 19%
Liabilities to Assets 6.0% 46.1% 3%
F-Score 2 4 7%

Microbot Medical Inc. did not pass any screens on 9/1/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors